Healthcare provider profile · identity verified

Eric William Miller, D.O.

Family Practice · OSKALOOSA, IA · NPI 1366707432

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	144
Lisinopril	Lisinopril	394	110
Amlodipine Besylate	Amlodipine Besylate	355	87
Levothyroxine Sodium	Levothyroxine Sodium	335	82
Omeprazole	Omeprazole	319	81
Losartan Potassium	Losartan Potassium	195	48
Rosuvastatin Calcium	Rosuvastatin Calcium	171	41
Metoprolol Succinate	Metoprolol Succinate	165	40
Gabapentin	Gabapentin	161	37
Furosemide	Furosemide	148	41
Metformin Hcl	Metformin Hcl	146	38
Hydrochlorothiazide	Hydrochlorothiazide	145	37
Duloxetine Hcl	Duloxetine Hcl	133	32
Tamsulosin Hcl	Tamsulosin Hcl	131	37
Simvastatin	Simvastatin	121	35
Metoprolol Tartrate	Metoprolol Tartrate	109	30
Potassium Chloride	Potassium Chloride	105	28
Trazodone Hcl	Trazodone Hcl	102	23
Albuterol Sulfate Hfa	Albuterol Sulfate	101	36
Pantoprazole Sodium	Pantoprazole Sodium	98	27
Allopurinol	Allopurinol	95	24
Ozempic	Semaglutide	95	18
Metformin Hcl Er	Metformin Hcl	94	26
Eliquis	Apixaban	92	20
Trulicity	Dulaglutide	85	14
Tresiba Flextouch U-100	Insulin Degludec	80	13
Finasteride	Finasteride	78	17
Lorazepam	Lorazepam	77	suppressed
Sertraline Hcl	Sertraline Hcl	71	17
Famotidine	Famotidine	70	14
Xarelto	Rivaroxaban	70	13
Glipizide Er	Glipizide	68	17
Benazepril Hcl	Benazepril Hcl	63	19
Pregabalin	Pregabalin	62	14
Tresiba Flextouch U-200	Insulin Degludec	56	suppressed
Warfarin Sodium	Warfarin Sodium	55	13
Montelukast Sodium	Montelukast Sodium	54	17
Pravastatin Sodium	Pravastatin Sodium	52	14
Citalopram Hbr	Citalopram Hydrobromide	51	12
Clopidogrel	Clopidogrel Bisulfate	51	13
Levetiracetam	Levetiracetam	49	suppressed
Tramadol Hcl	Tramadol Hcl	48	suppressed
Carvedilol	Carvedilol	47	12
Ropinirole Hcl	Ropinirole Hcl	46	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	12
Fluticasone Propionate	Fluticasone Propionate	45	13
Tizanidine Hcl	Tizanidine Hcl	45	15
Farxiga	Dapagliflozin Propanediol	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Donepezil Hcl	Donepezil Hcl	40	14
Prednisone	Prednisone	39	11
Buspirone Hcl	Buspirone Hcl	37	suppressed
Memantine Hcl	Memantine Hcl	37	11
Atenolol	Atenolol	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	12
Jardiance	Empagliflozin	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Naproxen	Naproxen	33	11
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	12
Spironolactone	Spironolactone	31	suppressed
Baclofen	Baclofen	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Glimepiride	Glimepiride	29	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Meloxicam	Meloxicam	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Celecoxib	Celecoxib	26	12
Alprazolam	Alprazolam	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Glipizide	Glipizide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Cephalexin	Cephalexin	18	16
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Valsartan	Valsartan	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Linzess	Linaclotide	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error